XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (100,625) $ (184,120)
Adjustments to reconcile net loss to cash provided by operating activities:    
Depreciation and amortization 134,591 138,490
Net amortization of debt discounts, premiums and issuance costs 45,973 50,454
Payment of accreted interest on senior secured notes (34,700) 0
Straight line rental income (309) (947)
Amortization of acquired real estate leases and other intangible assets, net 54 57
Loss on modification or early extinguishment of debt 29,197 209
Impairment of assets 69,465 18,687
(Gain) loss on sale of properties (102,711) 19,087
Gain on insurance recoveries (7,522) 0
Other non-cash adjustments, net (231) (387)
Unconsolidated joint venture distributions 0 1,231
Equity in net (earnings) losses of investees (4,569) 10,409
Change in assets and liabilities:    
Deferred leasing costs, net (2,690) (1,106)
Other assets 11,427 23,643
Accrued interest 313 380
Other liabilities 12,114 (3,193)
Net cash provided by operating activities 49,777 72,894
Cash flows from investing activities:    
Real estate improvements (73,831) (87,720)
Proceeds from sale of properties, net 334,108 7,318
Investment in AlerisLife Inc. 0 (15,459)
Equity method investment distribution 17,000 0
Contributions to unconsolidated joint ventures (8,500) 0
Proceeds from insurance recoveries 1,308 170
Purchase of interest rate cap (47) 0
Net cash provided by (used in) investing activities 270,038 (95,691)
Cash flows from financing activities:    
Proceeds from mortgage notes payable 343,157 120,000
Redemption of senior secured notes (238,555) 0
Redemption of senior unsecured notes (380,000) (60,000)
Repayment of other debt (1,659) (1,586)
Early extinguishment of debt settled in cash (25,903) 0
Payment of debt issuance costs (13,193) (7,564)
Repurchase of common shares (109) (121)
Distributions to shareholders (4,826) (4,808)
Net cash (used in) provided by financing activities (321,088) 45,921
(Decrease) increase in cash and cash equivalents and restricted cash (1,273) 23,124
Cash and cash equivalents and restricted cash at beginning of period 149,854 246,961
Cash and cash equivalents and restricted cash at end of period $ 148,581 $ 270,085